Key result
Chronic treatment with the NHE-1 inhibitor cariporide greatly attenuated the development of cardiac hypertrophy and entirely abolished the development of heart failure in rabbits.
Why the study?
Does chronic inhibition of NHE-1 with cariporide prevent cardiac hypertrophy and cellular remodeling in a rabbit model of volume and pressure overload?
Does chronic inhibition of NHE-1 with cariporide prevent cardiac hypertrophy and cellular remodeling in a rabbit model of volume and pressure overload?
In a rabbit model of volume and pressure overload, chronic NHE-1 inhibition with cariporide attenuated cardiac hypertrophy and prevented the development of heart failure and cellular remodeling.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for NHE-1 inhibition in overload HF; human trials needed before any clinical consideration.
OBJECTIVE: In patients with heart disease, the transition from compensatory hypertrophy to heart failure (HF) is associated with altered calcium handling. Up-regulated Na(+)/H(+)-exchanger (NHE-1) activity underlies increased [Na(+)](i) and disturbance of cellular calcium handling in HF. We hypothesize that chronic inhibition of NHE-1 activity prevents the hypertrophic response, cellular remodeling, and development of HF. METHODS: Rabbits received a control or cariporide (inhibitor of NHE-1) diet for 3 months, starting after induction of combined volume and pressure overload. Age-matched animals served as control. Development of HF was examined echocardiographically and electrocardiographically after 3 months. [Na(+)](i), [Ca(2+)](i), pH(i), and action potentials were measured in left ventricular midmural myocytes with SBFI, indo-1, SNARF, and di-4-anepps. Sarcoplasmic reticulum calcium content was calculated from the response of [Ca(2+)](i) to rapid cooling. Calcium after-transients were elicited by cessation of rapid stimulation (3 Hz) in the presence of 100 nmol/l noradrenalin. RESULTS: Chronic treatment of rabbits with the specific Na(+)/H(+)-exchanger activity inhibitor cariporide greatly attenuated development of hypertrophy and entirely abolished development of HF; the heart/body weight ratio increased only little, no change in lung weight occurred, left ventricular dimensions and fractional shortening changed mildly, ascites was not present, QT duration did not increase, and sudden death did not occur. Chronic cariporide treatment also prevented cellular electrical and ionic remodeling. Myocyte dimensions were unaltered, action potentials were not prolonged, cytoplasmic sodium and NHE-1 activity did not increase, cytoplasmic and SR calcium handling remained undisturbed, and no increase of the incidence of calcium after-transient dependent delayed after depolarizations (DADs) occurred. CONCLUSION: We conclude that enhanced activity of NHE-1 underlies cardiac cellular electrical and ionic remodeling in experimental heart failure, and that chronic dietary treatment with cariporide attenuates hypertrophy, development of HF, and cellular remodeling.
No takes yet. Share an insight, caveat, or question.
Baartscheer et al. (2004) studied Heart failure and cardiac hypertrophy. Cariporide vs. Control diet was evaluated on Development of hypertrophy and heart failure. Chronic treatment with the NHE-1 inhibitor cariporide greatly attenuated the development of cardiac hypertrophy and entirely abolished the development of heart failure in rabbits.
Synapse has enriched 10 related papers. Consider them for comparative context: